LGM Pharma announces a $6M investment to expand its Rosenberg, Texas facility, enhancing its capacity for liquid, semi-solid and suppository drug production. The expansion supports growing prescription drug demand.

BIOVECTRA, part of Agilent Technologies, has been awarded the 2025 Outsourced Pharma CDMO Leadership Award in biologics for its exceptional quality, reliability and technical capability.

On February 28, 2025, WHO announced the recommended strains for the 2025-2026 northern hemisphere influenza season.

Thermo Fisher Scientific introduces the Thermo Scientific™ TSX™ Core Series ULT freezers, designed to provide reliable performance and robust durability in a user-friendly solution.

Azenta Life Sciences offers a wide range of sample management solutions to assist biobanks in the protection of sample integrity and security while maintaining easy access to samples and facilitating quick sample retrieval.

Sphere Fluidics announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development.

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), announced the signing of a multi-year commercial manufacturing agreement with LINDIS Biotech.

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, announced the launch of ClinFAST™, a service designed to assist clinical stage biotech and pharma companies.

In the rapidly advancing world of laboratory research, precision is more critical than ever. Anticipating this demand, Micronic introduces X-Clear Tubes—the first on the market to deliver unmatched optical clarity and optimal light transmittance.

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a cell-engineering focused company announced the acquisition of SeQure Dx.